Early Time-Restricted Eating in Young Judo Athletes (TRE-JUDO)
Effects of a 5-Month Early Time-Restricted Eating Protocol on Body Composition, Muscle Damage Biomarkers, Competitive Anxiety, and Self-Confidence in Highly Trained Young Judo Athletes: A Randomized Controlled Trial
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
This study was designed to evaluate the effects of a 5-month early time-restricted eating (e-TRE) intervention on physiological and psychological outcomes in highly trained young male judo athletes. The study included 100 participants recruited from competitive judo teams in Tunisia. Participants were randomly assigned to either an e-TRE group or a control group in a 1:1 ratio.
The e-TRE group followed a structured 16:8 time-restricted eating protocol, consuming all daily energy intake within an 8-hour window from 07:00 to 15:00, followed by a 16-hour fasting period. During fasting hours, only non-caloric beverages were permitted. The control group maintained their habitual dietary intake and meal timing without any modifications. Both groups continued their regular judo training program, consisting of 5-6 training sessions per week, including technical drills, sparring (randori), and strength and conditioning exercises.
Anthropometric and biochemical measurements were collected at baseline (T0) and after the 5-month intervention (T1). Psychological assessments were conducted before monthly competitions throughout the study period. Blood samples were collected under standardized resting conditions and analyzed using validated enzymatic and immunoassay techniques.
Participants were required to meet strict inclusion criteria, including age 18-26 years, male sex, at least 3 years of judo training experience, and absence of metabolic, psychiatric, or chronic diseases. Exclusion criteria included use of medications or supplements affecting metabolism, prior experience with intermittent fasting, and conditions that could affect training or biomarker outcomes.
The study was approved by the Ethics Committee of the Higher Institute of Sport and Physical Education of Ksar Said, University of Manouba, Tunisia (approval No. 0171823; organization's unique protocol ID: ISSEP-2026-023) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to enrollment
Statistical analyses included repeated-measures ANOVA to assess group × time effects, with significance set at p < 0.05. Effect sizes were calculated using partial eta squared (η²).
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Manouba
-
Manouba, Manouba, Tunísia, 2009
- Higher Institute of Sport and Physical Education of Manouba (ISSEP Manouba)
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
- Adulto
Aceita Voluntários Saudáveis
Descrição
Inclusion Criteria:
- aged 19-26 years;
- male judo players; c) with at least 3 years of judo training experience;
- engaged in judo training 5-6 days per week; e) healthy, with no known chronic illnesses or conditions affecting metabolism, mental health, or physical performance;
- willing to adhere to a 16:8 e-TRE protocol for the 5-month study period;
- non-smokers, as smoking may affect anxiety levels and cardiovascular health;
- not using any performance-enhancing drugs or supplements that could interfere with the study's measurements.
Exclusion Criteria:
- current musculoskeletal injuries or conditions that could limit participation in training or affect muscle damage biomarkers;
- diagnosed psychiatric disorders or current treatment for anxiety or mood disorders, as these could interfere with psychological assessments;
- use of medications affecting metabolism, muscle recovery, or psychological state (e.g., corticosteroids, antidepressants);
- prior experience with time-restricted eating or intermittent fasting within the past year, as prior adaptation could impact study outcomes;
- dietary restrictions or practices (e.g., vegan or keto diet) that could affect nutrient intake or metabolic markers;
- diagnosed sleep disorders or irregular sleep patterns, as sleep quality could impact both muscle recovery and psychological parameters;
- inability to commit to the structured training program over the study period.
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Tratamento
- Alocação: Randomizado
- Modelo Intervencional: Atribuição Paralela
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Early Time-Restricted Eating (e-TRE) Group
Participants in this group followed a 16:8 early time-restricted eating protocol for 5 months.
Participants maintained their usual training program throughout the intervention period.
|
The intervention consisted of a 16:8 early time-restricted eating protocol applied for 5 months.
Participants consumed all meals between 07:00 and 15:00, followed by a fasting period from 15:00 to 07:00 the next day.
Only non-caloric beverages were allowed during fasting hours.
Participants continued their regular judo training (5-6 sessions per week) without modifications.
Dietary guidance was provided to support adherence to the eating schedule.
|
|
Sem intervenção: Control Group
Participants in this group maintained their habitual dietary practices.
They continued their regular judo training program throughout the 5-month study period.
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Competitive Anxiety and Self-Confidence
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Competitive anxiety and self-confidence will be assessed using the Competitive State Anxiety Inventory-2 (CSAI-2). This validated questionnaire measures three dimensions of pre-competition psychological state: cognitive anxiety, somatic anxiety, and self-confidence. Scores will be used to evaluate changes in athletes' psychological readiness, emotional response to competition, and perceived self-efficacy. The CSAI-2 consists of 27 items, divided into three subscales (9 items each). Each item is rated on a 4-point Likert scale ranging from 1 ("not at all") to 4 ("very much so"). Subscale scores are calculated by summing item responses, resulting in a score range of 9 to 36 for each dimension (cognitive anxiety, somatic anxiety, and self-confidence). Measurements will be taken at baseline (T0) and post-intervention (T1) to determine the effect of early time-restricted eating on competitive anxiety and self-confidence in young judo athletes. |
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Creatine kinase (CK)
Prazo: Baseline and 5 months (pre-intervention and post-intervention)]
|
Creatine kinase (CK) will be used as a marker of muscle damage.
Blood samples will be collected to assess changes in CK levels in response to the early time-restricted eating intervention.
CK concentrations will be measured in U/L and compared between baseline (T0) and post-intervention (T1, 5 months) in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)]
|
|
Lactate dehydrogenase (LDH)
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Lactate dehydrogenase (LDH) will be used as a biomarker of muscle damage.
LDH will be measured in U/L to assess changes induced by early time-restricted eating between baseline and post-intervention in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Aspartate aminotransferase (AST)
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Aspartate aminotransferase (AST) will be measured as an indirect marker of muscle damage and metabolic stress.
AST levels will be assessed in U/L to evaluate changes from baseline to post-intervention following early time-restricted eating in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Alanine aminotransferase (ALT)
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Alanine aminotransferase (ALT) will be assessed as a biomarker related to muscle stress.
ALT levels will be measured in U/L to determine changes following early time-restricted eating between baseline and post-intervention in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Uric acid
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Uric acid will be measured as a metabolic and oxidative stress biomarker.
Serum uric acid will be assessed in µmol/L to evaluate changes induced by early time-restricted eating in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
C-reactive protein (CRP)
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
C-reactive protein (CRP) will be used as a systemic inflammation biomarker.
CRP levels will be measured in mg/L to assess inflammatory response changes following early time-restricted eating between baseline and post-intervention in judo athletes.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Total bilirubin
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Total bilirubin will be measured as a marker of oxidative stress and heme metabolism.
Serum bilirubin levels will be assessed in µmol/L to evaluate changes induced by early time-restricted eating in judo athletes between baseline and post-intervention.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Body Mass Index (BMI)
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Body Mass Index (BMI) will be calculated as body weight in kilograms divided by height in meters squared (kg/m²).
BMI will be used to assess changes in overall body composition status following early time-restricted eating.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Body fat percentage
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Body fat percentage will be assessed as an indicator of relative adiposity.
Body fat percentage will be expressed as a percentage (%) and measured to evaluate changes following the early time-restricted eating intervention.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
|
Skeletal muscle mass
Prazo: Baseline and 5 months (pre-intervention and post-intervention)
|
Skeletal muscle mass will be assessed as an indicator of lean muscle tissue.
Skeletal muscle mass will be measured in kilograms (kg) to evaluate changes induced by early time-restricted eating.
|
Baseline and 5 months (pre-intervention and post-intervention)
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- ISSEP-2026-023
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .